PW
ABBV icon

Paladin Wealth’s AbbVie ABBV Stock Holding History

Paladin Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$212K Buy
+844
New +$182K 0.12% 123
2024
Q4 		– Sell
-856
Closed -$169K – 96
2024
Q3 		$169K Buy
+856
New +$160K 0.15% 101

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Paladin Wealth's ABBV Position: Q2 2026 in Review

Paladin Wealth opened a new position in AbbVie (ABBV) in Q2 2026: 844 shares worth $212K. The stake represents 0.12% of the portfolio and ranks #123 among its holdings. This is a return to the name: Paladin Wealth previously reported a position in ABBV as recently as Q3 2024.

Paladin Wealth first reported a position in ABBV in Q3 2024 and has held it in 2 quarters since. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Paladin Wealth held 844 shares of AbbVie worth $212K as of Q2 2026.
  • AbbVie was a new Paladin Wealth position in Q2 2026.
  • AbbVie made up 0.12% of Paladin Wealth's portfolio in Q2 2026, its #123 holding.
  • Paladin Wealth first reported a position in AbbVie in Q3 2024 and has held it in 2 quarters since.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Paladin Wealth's 13F filing for Q2 2026, filed 9 Jul 2026.